Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03097991 · ClinicalTrials.gov registry record · NA

Randomized Controlled Trial of Prenatal Coparenting Intervention (CoparentRCT)

A NA study, sponsored by University of South Florida.

Completed
Registry status
NA
Development phase
276
Enrollment target

NCT03097991: Completed NA study, sponsored by University of South Florida.

NCT03097991 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 276 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03097991, a NA study, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
NA
Development phase
276 participants
Enrollment target

Study Summary

This R01 tests through RCT methodology efficacy of a new intervention designed specifically to aid development of positive coparenting alliances between at-risk (unmarried, uncoupled, low income) African American mothers and fathers having a first baby together.

Primary Outcome

Composite of SCID observational measures of positive mother-father interaction (Problem Solving Communication\*\*, Support\*\*, Cohesiveness\*, Withdrawal\*\*, Positive Affect\*\*) \* Couple variable, there is only one score for the couple. \*\* Individual variable, there are two separate scores for mothers and fathers separately. Each sub-scale scores range from 1 to 5. Total scale scores were combined by averaging the individual and couple scales, with higher scores indicating more positive

Interventions

  • BEHAVIORAL Focused Coparenting Consultation

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2015-09-26
Est. Completion 2021-12-18
Phase NA
University of South Florida

252 total trials

What the finished NCT03097991 record still lists

NCT03097991 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 1 intervention - of which Focused Coparenting Consultation is the first listed.

NCT03097991 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03097991 about?

NCT03097991 is a clinical study titled "Randomized Controlled Trial of Prenatal Coparenting Intervention (CoparentRCT)". This R01 tests through RCT methodology efficacy of a new intervention designed specifically to aid development of positive coparenting alliances between at-risk (unmarried, uncoupled, low income) African American mothers and fathers having a first baby together.

What is the current status of trial NCT03097991?

This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2015-09-26. Estimated completion is 2021-12-18.

What interventions are being tested in trial NCT03097991?

The interventions under investigation include: Focused Coparenting Consultation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03097991?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03097991's enrollment target sits among peer trials

276 383rd of 2000 higher than 1,618 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01371630 · 276 participants · Phase 1

    Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

  • NCT04192344 · 276 participants · Phase 1

    A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

  • NCT05294991 · 276 participants · NA

    Wellness App for Sleep Disturbance in Hematological Cancer Patients

  • NCT05610852 · 276 participants · NA

    Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03097991, the US trial registry maintained by the National Library of Medicine. NCT03097991 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.